Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced the ...

EQT Life Sciences is pleased to announce that the LSP 7 fund has invested in Noema Pharma ("the Company"). The clinical-stage biotech company headquartered in Basel, Switzerland is developing a ...

STOCKHOLM--Swedish buyout group EQT led a series B funding extension for Swiss biotech company Noema Pharma. Noema Pharma is developing a pipeline of therapeutics that address central nervous system ...

Noema Pharma, a Swiss biotech targeting debilitating central nervous system (CNS) disorders, has announced the successful ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

EGM was convened today on 11 December 2024. In accordance with the Nomination Committee's proposals, David Meek was elected as new member of the Board of Directors and Chair of the Board of Directors ...

NaturVet announces Willie Post as the Executive Director of U.S. Sales. With over 35 years of experience in business and sales leadership at renowned companies like Pfizer, Johnson & Johnson, Reckitt ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

With COP27 concluding in November, Ben Hargreaves takes a look at what efforts pharma companies are making to limit their environmental impact. The past eight years are set to be the eight warmest ...

Destiny Pharma has joined a growing list of UK biotechs seeking to delist from the Alternative Investments Market (AIM) and return to private ownership. The Brighton-based company, which will put ...